Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Combined Automated Blood Tests Estimate Prostate Cancer Probability

By LabMedica International staff writers
Posted on 19 Apr 2010
Three automated blood tests combined into one index estimates a man's probability of having prostate cancer found on biopsy.

A new prostate disease marker, p2prostate-specific antigen (p2PSA), and the Prostate Health Index (phi), significantly improve the specificity of prostate cancer biomarker assessment. More...


Serum Beckman Coulter (Nyon, Switzerland) phi is a multivariate index incorporating prostate-specific antigen (PSA), free PSA, and proPSA concentrations into a single result. This enables medical professionals to estimate the probability of cancer in men aged 50 and older with total PSA in the 2.0-10.0 ng/mL range and a nonsuspicious digital rectal examination (DRE).

proPSA is a novel serum marker strongly associated with prostate cancer and delivers added specificity to PSA. As a result, phi contributes to reduce significantly the number of negative biopsies resulting from suspicious PSA or free PSA results.

Beckman Coulter phi is a composite score of Access Hybritech PSA, free PSA and the new p2PSA assay, which measures the isoform proPSA.

A new website introduced by Beckman Coulter, was designed to encourage dialogue between patients, physicians, and laboratory professionals. It provides guidance and education to all parties in order to foster confident prostate biopsy decision-making. The website (please see related links below) provides links to credible medical resources, the latest unbiased scientific studies, and details the benefits of the latest blood test, which can noninvasively identify patients who are most likely to have a negative prostate biopsy.

Related Links:

Beckman Coulter

Prostate Health Index



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The model estimated about a fivefold return in gastric cancer prevention benefits per unit invested, with cost-effectiveness maintained in higher-cost settings (Image credit: Adobe Stock)

H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention

Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.